Optiver Holding
ANIK icon

Optiver Holding’s Anika Therapeutics ANIK Stock Holding History

Optiver Holding’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29 Sell
2
-112
-98% -$1.66K ﹤0.01% 2691
2026
Q1 		$1.65K Sell
114
-104
-48% -$1.21K ﹤0.01% 1921
2025
Q4 		$2.1K Hold
218
– – ﹤0.01% 1988
2025
Q3 		$2.05K Buy
+218
New +$2.08K ﹤0.01% 2375

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Optiver Holding's ANIK Position: Q2 2026 in Review

Optiver Holding reduced its Anika Therapeutics (ANIK) stake by 98% in Q2 2026, selling an estimated $1.66K and leaving 2 shares worth $29. The position accounts for ﹤0.01% of the portfolio, ranked #2691.

Optiver Holding first reported a position in ANIK in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.1K in Q4 2025. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Optiver Holding held 2 shares of Anika Therapeutics worth $29 as of Q2 2026.
  • Optiver Holding sold 112 Anika Therapeutics shares in Q2 2026, an estimated $1.66K.
  • Anika Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2691 holding.
  • Optiver Holding first reported a position in Anika Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Anika Therapeutics position peaked at $2.1K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.